Skip to main content
 Home
  • Dansk
  • English

Servicemenu

  • News
  • Events
    • Previous Events
  • Themes
  • Contact
    • Contact Grants & Prizes
    • Press Contact
    • Contact The Lundbeck Foundation
    • Departments
    • Logo and Design

Hovedmenu

  • Business Activities
    • Lundbeckfonden BioCapital
      • About Lundbeckfonden BioCapital
      • Lundbeckfonden BioCapital News
      • Lundbeckfonden BioCapital Portfolio
      • Lundbeckfonden BioCapital Portfolio News
    • Strategic Investments
      • Long-Term Value Creation
      • Strategic Ownership
    • Invest
  • Grants & Prizes
    • For applicants
      • Apply for grants
      • Processing of applications
      • Review Panels
    • For grant recipients
      • Terms and Conditions - Research Grants
      • Reporting
      • Distribution of funds
    • What we have funded
      • Fellowships
      • Professorships
      • Ascending Investigators
      • Pre-Graduate Scholarships
      • LF Postdocs
      • Visiting Professorships
      • LF Experiment
      • Talentpriser
      • The Brain Prize
      • Young Investigator Prize
      • Alle
    • News - Grants & Prizes
    • Research Stories
  • Neurotorium
  • The Brain Prize
    • Overview
    • Nominations & Selection Process
    • Press and Logo
    • News
  • About Us
    • The Organisation
      • Board of Directors and Management
      • Vacancies
    • Who are we?
    • History and Statutes
    • Strategy and Purpose
      • Bringing Discoveries to Lives
    • Social Responsibility and Transparency
      • Recommendations on Foundation Governance, Corporate Governance and Transparency
      • Governance
      • Active voice in public debate
      • Policies
      • Whistleblower
    • Publikationer
      • Annual Reports
      • Sustainability Reports
      • The Magazine
      • Anniversary Book
  • Apply and Nominate

Hovedmenu - mobil

  • Business Activities
    • Lundbeckfonden BioCapital
      • About Lundbeckfonden BioCapital
      • Lundbeckfonden BioCapital News
      • Lundbeckfonden BioCapital Portfolio
      • Lundbeckfonden BioCapital Portfolio News
    • Strategic Investments
      • Long-Term Value Creation
      • Strategic Ownership
    • Invest
  • Grants & Prizes
    • For applicants
      • Apply for grants
      • Processing of applications
      • Review Panels
    • For grant recipients
      • Terms and Conditions - Research Grants
      • Reporting
      • Distribution of funds
    • What we have funded
      • Fellowships
      • Professorships
      • Ascending Investigators
      • Pre-Graduate Scholarships
      • LF Postdocs
      • Visiting Professorships
      • LF Experiment
      • Talentpriser
      • The Brain Prize
      • Young Investigator Prize
      • Alle
    • News - Grants & Prizes
    • Research Stories
  • Neurotorium
  • The Brain Prize
    • Overview
    • Nominations & Selection Process
    • Press and Logo
    • News
  • About Us
    • The Organisation
      • Board of Directors and Management
      • Vacancies
        • Personal Data Policy for Recruitment
    • Who are we?
    • History and Statutes
    • Strategy and Purpose
      • Bringing Discoveries to Lives
    • Social Responsibility and Transparency
      • Recommendations on Foundation Governance, Corporate Governance and Transparency
      • Governance
      • Active voice in public debate
      • Policies
      • Whistleblower
    • Publikationer
      • Annual Reports
      • Sustainability Reports
      • The Magazine
      • Anniversary Book
  • Apply and Nominate

Servicemenu - mobil

  • News
  • Events
    • Previous Events
  • Themes
  • Analyser
  • Contact
    • Contact Grants & Prizes
    • Press Contact
    • Contact The Lundbeck Foundation
    • Departments
    • Logo and Design
  • Dansk
  • English

Breadcrumb

  1. Home
  2. Business Activities
  3. Lundbeckfonden BioCapital
  4. SNIPR Biome

SNIPR Biome

SNIPR Biome is a preclinical biotech company developing CRISPR based therapeutics with the goal of modulating the human microbiome through precision elimination of pathogenic bacteria.

SNIPR also presents a potent alternative to treating antibiotic-resistant bacteria through its CRISPR mode of action and the development of various drug modalities

 

Related news about SNIPR Biome

  • Precedential US Federal Court Decision Hands SNIPR Biome a win in patent appeal over Rockefeller University for CRISPR-Cas microbial gene editing
  • SNIPR Biome reports positive clinical interim results for groundbreaking, first-in-human, CRISPR-based microbial gene therapy
  • SNIPR Biome's data on first clinical drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology
  • SNIPR Biome further strengthens CRISPR/Cas IP portfolio with patent grant
  • SNIPR Biome Granted New US Patent Covering Lytic CRISPR Phage
SNIPR Biome logo
SNIPR Biome's website

Lundbeckfonden BioCapital

Invested
2017
Location

Copenhagen, Denmark

Contact

Christian Elling

Christian Elling

Managing Partner Lundbeckfonden BioCapital

cee@lundbeckfonden.com
Mobile

+45 2062 1276

Lundbeckfonden invests 2.0 bn yearly, in emerging biotech companies

Visit our portfolio
Footer logo
The Lundbeck Foundation annually distributes more than DKK 500 mio. to Danish-based healthcare science research, primarily with a focus on the brain.

Lundbeckfonden
Scherfigsvej 7
2100 København Ø

CVR
11814913

Links

  • Cookie-Policy
  • Disclaimer & Privacy
  • History and Statutes
  • Our Strategy
  • Events
  • Contact
  • Jobs
Follow us
Facebook
Twitter
LinkedIn
Youtube